Major

Neuroscience

Anticipated Graduation Year

2023

Access Type

Open Access

Abstract

Sustained remission of acute myeloid leukemia (AML) is negated by the proliferation of leukemia stem cells (LSCs) that survive first-line chemotherapy. Thus, there is a dire need for additional, LSC-specific therapies that can help prevent relapse. TBK1, a serine/ threonine kinase, has been implicated in the pathogenesis of AML, possibly due to its ability to promote MYC activity and FLT3 expression. Additionally, high TBK1 mRNA expression has been associated with a reduced probability of AML survival. We hypothesize that TBK1 inhibition could antagonize the stem-like characteristics of LSCs, promoting their loss-of-function death and increasing the odds of achieving a cure.

Community Partners

Department of Cancer Biology, Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Medical Center

Faculty Mentors & Instructors

Jiwang Zhang, MD, PhD; Austin P. Runde, MS Student in Cellular and Molecular Oncology; Fr. Peter Breslin, S.J.

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Share

COinS
 

Investigating the role of TANK-binding kinase 1 (TBK1) in MLL-AF9+ acute myeloid leukemia.

Sustained remission of acute myeloid leukemia (AML) is negated by the proliferation of leukemia stem cells (LSCs) that survive first-line chemotherapy. Thus, there is a dire need for additional, LSC-specific therapies that can help prevent relapse. TBK1, a serine/ threonine kinase, has been implicated in the pathogenesis of AML, possibly due to its ability to promote MYC activity and FLT3 expression. Additionally, high TBK1 mRNA expression has been associated with a reduced probability of AML survival. We hypothesize that TBK1 inhibition could antagonize the stem-like characteristics of LSCs, promoting their loss-of-function death and increasing the odds of achieving a cure.